Recently, many sponsors have experienced rising demand from regulators and payers to carry out cardiovascular outcomes trials (CVOT), not only for mandated for type 2 diabetes products but increasingly for other diseases and indications. This infographic addresses some of the frequently asked questions surrounding CVOTs presented from a former Cardiovascular Safety Outcome Trials Think Tank Meeting.
Have you considered:
- If you need a CVOT to support your product journey?
- What are the key considerations for performing a CVOT?
- When should a CVOT be carried out?